The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

LGP by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Index approaches record high as Austal spikes on US Navy contract | September 16, 2024

The ASX200 closed up a 0.27% at 8,121 points, as the market came within a whisker…
  • Sean Boss
  • 2 mins
  • 16 September 2024 17:26 (AEST)
The Market Online Video

ASX Market Update: Aussie Index on the cusp of record as Real Estate stocks take the lead | September 16, 2024

The ASX200 has been up around point four six of a percent at 8,137 points. The…
America uncertainty concept

Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week

At the time of writing this article – 12pm Sydney time on Monday – US futures…
Image of a nugget of gold

Flynn finds multiple veins of gold through diamond drilling in Tasmania

Flynn Gold Ltd has progressed diamond drilling across the Trafalgar North zone at its Golden Ridge…